Award
Award #75N98026D00103
Long-Term In Vitro Antimicrobial Activity Assessment Contract with HMH Hospitals
Buyer
National Institutes of Health
Award Amount
$2,500.00
Ceiling
$2,500.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2036
Identifier
75N98026D00103
NAICS
541714
This indefinite-delivery vehicle (IDV) contract was awarded to HMH Hospitals Corporation, a healthcare organization specializing in medical and clinical services, to conduct extensive in vitro assessments of antimicrobial activity. The contract focuses on laboratory testing and analysis to evaluate the efficacy of antimicrobial agents, a crucial task for advancing medical research and public health by combating resistant infections and improving treatment outcomes. The long-term agreement highlights the agency's commitment to sustained monitoring and evaluation of antimicrobial effectiveness over a significant multi-year period. Awarded through competitive processes typical for IDV contracts, it ensures high standards of service quality and cost-efficiency. The contract covers comprehensive laboratory work with a performance period spanning approximately a decade, underscoring its importance in supporting public health safety and medical research initiatives.
Description
IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)